LNC develop microbiome modulators to tackle obesity and its adjacent cardiometabolic diseases.
Driven by a highly qualified and passionate team, LNC is a R&D company focused on adipocyte dysfunction and adipose tissue inflammation, to treat the underlying causes of metabolic diseases. LNC designs and develops clinically proven, safe and effective and patented Medical Food formulas.
Site Internet : http://www.l-n-c.fr/
Contact : Guez Fabrice, laboratoire-nutrition-cardiometabolisme-lnc - Sud-Ouest Disrupt.